Open access
Sep 2026
Synthesis, anti-proliferative evaluation, DFT, in silico ADME and molecular modeling studies of novel imidazolones as potential EGFR inhibitors
Findings identify bromophenyl-substituted imidazolone derivatives, particularly compound 5, as promising anticancer lead candidates, while suggesting EGFR as a plausible molecular target.
Mohamed H. Hekal, Mohamed Abdel-Megid, Mostafa E. Salem et al.
· RSC Advances · 0 citations